-
1
-
-
34548133584
-
Multiple sclerosis: A complicated picture of autoimmunity
-
DOI 10.1038/ni1507, PII NI1507
-
McFarland, H. F., and R. Martin. 2007. Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 8: 913-919. (Pubitemid 47300005)
-
(2007)
Nature Immunology
, vol.8
, Issue.9
, pp. 913-919
-
-
McFarland, H.F.1
Martin, R.2
-
2
-
-
35848956116
-
The contribution of nitric oxide and interferon gamma to the regulation of the neuro-inflammation in experimental autoimmune encephalomyelitis
-
DOI 10.1016/j.jneuroim.2007.09.007, PII S0165572807003116, Regulation of Neuroinflammation
-
Willenborg, D. O., M. Staykova, S. Fordham, N. O'Brien, and D. Linares. 2007. The contribution of nitric oxide and interferon gamma to the regulation of the neuro-inflammation in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 191: 16-25. (Pubitemid 350060995)
-
(2007)
Journal of Neuroimmunology
, vol.191
, Issue.1-2
, pp. 16-25
-
-
Willenborg, D.O.1
Staykova, M.2
Fordham, S.3
O'Brien, N.4
Linares, D.5
-
3
-
-
80053307800
-
TNF-a: A paradigm of paradox and complexity in multiple sclerosis and its animal models
-
Lim, S.-Y., and C. Constantinescu. 2010. TNF-a: a paradigm of paradox and complexity in multiple sclerosis and its animal models. Open Autoimmun. J. 2: 160-170.
-
(2010)
Open Autoimmun. J.
, vol.2
, pp. 160-170
-
-
Lim, S.-Y.1
Constantinescu, C.2
-
4
-
-
12644261423
-
Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: Implications for the treatment of multiple sclerosis
-
DOI 10.1073/pnas.94.6.2528
-
Hooper, D. C., O. Bagasra, J. C. Marini, A. Zborek, S. T. Ohnishi, R. Kean, J. M. Champion, A. B. Sarker, L. Bobroski, J. L. Farber, et al. 1997. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc. Natl. Acad. Sci. USA 94: 2528-2533. (Pubitemid 27136909)
-
(1997)
Proceedings of the National Academy of Sciences of the United States of America
, vol.94
, Issue.6
, pp. 2528-2533
-
-
Hooper, D.C.1
Bagasra, O.2
Marini, J.C.3
Zborek, A.4
Ohnishi, S.T.5
Kean, R.6
Champion, J.M.7
Sarker, A.B.8
Bobroski, L.9
Farber, J.L.10
Akaike, T.11
Maeda, H.12
Koprowski, H.13
-
5
-
-
0028855346
-
Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I
-
Selmaj, K., W. Papierz, A. Glabiński, and T. Kohno. 1995. Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. J. Neuroimmunol. 56: 135-141.
-
(1995)
J. Neuroimmunol.
, vol.56
, pp. 135-141
-
-
Selmaj, K.1
Papierz, W.2
Glabiński, A.3
Kohno, T.4
-
6
-
-
7044253039
-
CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis
-
Rejdak, K., M. J. Eikelenboom, A. Petzold, E. J. Thompson, Z. Stelmasiak, R. H. Lazeron, F. Barkhof, C. H. Polman, B. M. Uitdehaag, and G. Giovannoni. 2004. CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis. Neurology 63: 1439-1445. (Pubitemid 39426278)
-
(2004)
Neurology
, vol.63
, Issue.8
, pp. 1439-1445
-
-
Rejdak, K.1
Eikelenboom, M.J.2
Petzold, A.3
Thompson, E.J.4
Stelmasiak, Z.5
Lazeron, R.H.C.6
Barkhof, F.7
Polman, C.H.8
Uitdehaag, B.M.J.9
Giovannoni, G.10
-
7
-
-
38549152194
-
Principles of bioactive lipid signalling: Lessons from sphingolipids
-
DOI 10.1038/nrm2329, PII NRM2329
-
Hannun, Y. A., and L. M. Obeid. 2008. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat. Rev. Mol. Cell Biol. 9: 139-150. (Pubitemid 351158911)
-
(2008)
Nature Reviews Molecular Cell Biology
, vol.9
, Issue.2
, pp. 139-150
-
-
Hannun, Y.A.1
Obeid, L.M.2
-
8
-
-
78649761056
-
Sphingolipids in multiple sclerosis
-
Jana, A., and K. Pahan. 2010. Sphingolipids in multiple sclerosis. Neuromolecular Med. 12: 351-361.
-
(2010)
Neuromolecular Med.
, vol.12
, pp. 351-361
-
-
Jana, A.1
Pahan, K.2
-
9
-
-
78649790713
-
The role of the ceramide acyl chain length in neurodegeneration: Involvement of ceramide synthases
-
Ben-David, O., and A. H. Futerman. 2010. The role of the ceramide acyl chain length in neurodegeneration: involvement of ceramide synthases. Neuromolecular Med. 12: 341-350.
-
(2010)
Neuromolecular Med.
, vol.12
, pp. 341-350
-
-
Ben-David, O.1
Futerman, A.H.2
-
10
-
-
77954709548
-
The acid sphingomyelinase/ceramide pathway: Biomedical significance and mechanisms of regulation
-
Zeidan, Y. H., and Y. A. Hannun. 2010. The acid sphingomyelinase/ceramide pathway: biomedical significance and mechanisms of regulation. Curr. Mol. Med. 10: 454-466.
-
(2010)
Curr. Mol. Med.
, vol.10
, pp. 454-466
-
-
Zeidan, Y.H.1
Hannun, Y.A.2
-
11
-
-
77953461364
-
The role of sphingolipids and ceramide in pulmonary inflammation in cystic fibrosis
-
Becker, K. A., J. Riethmüller, Y. Zhang, and E. Gulbins. 2010. The role of sphingolipids and ceramide in pulmonary inflammation in cystic fibrosis. Open Respir. Med. J. 4: 39-47.
-
(2010)
Open Respir. Med. J.
, vol.4
, pp. 39-47
-
-
Becker, K.A.1
Riethmüller, J.2
Zhang, Y.3
Gulbins, E.4
-
12
-
-
0035217962
-
Modes of action of Freund's adjuvants in experimental models of autoimmune diseases
-
Billiau, A., and P. Matthys. 2001. Modes of action of Freund's adjuvants in experimental models of autoimmune diseases. J. Leukoc. Biol. 70: 849-860. (Pubitemid 33151123)
-
(2001)
Journal of Leukocyte Biology
, vol.70
, Issue.6
, pp. 849-860
-
-
Billiau, A.1
Matthys, P.2
-
13
-
-
0024518801
-
The long-term administration of L-cycloserine to mice: Specific reduction of cerebroside level
-
DOI 10.1007/BF00971318
-
Sundaram, K. S., and M. Lev. 1989. The long-term administration of L-cycloserine to mice: specific reduction of cerebroside level. Neurochem. Res. 14: 245-248. (Pubitemid 19132454)
-
(1989)
Neurochemical Research
, vol.14
, Issue.3
, pp. 245-248
-
-
Sundaram, K.S.1
Lev, M.2
-
14
-
-
45649083068
-
The anti-proliferative potency of celecoxib is not a class effect of coxibs
-
Schiffmann, S., T. J. Maier, I. Wobst, A. Janssen, H. Corban-Wilhelm, C. Angioni, G. Geisslinger, and S. Grösch. 2008. The anti-proliferative potency of celecoxib is not a class effect of coxibs. Biochem. Pharmacol. 76: 179-187.
-
(2008)
Biochem. Pharmacol.
, vol.76
, pp. 179-187
-
-
Schiffmann, S.1
Maier, T.J.2
Wobst, I.3
Janssen, A.4
Corban-Wilhelm, H.5
Angioni, C.6
Geisslinger, G.7
Grösch, S.8
-
15
-
-
77957924527
-
Activation of ceramide synthase 6 by celecoxib leads to a selective induction of C16: 0-ceramide
-
Schiffmann, S., S. Ziebell, J. Sandner, K. Birod, K. Deckmann, D. Hartmann, S. Rode, H. Schmidt, C. Angioni, G. Geisslinger, and S. Grösch. 2010. Activation of ceramide synthase 6 by celecoxib leads to a selective induction of C16: 0-ceramide. Biochem. Pharmacol. 80: 1632-1640.
-
(2010)
Biochem. Pharmacol.
, vol.80
, pp. 1632-1640
-
-
Schiffmann, S.1
Ziebell, S.2
Sandner, J.3
Birod, K.4
Deckmann, K.5
Hartmann, D.6
Rode, S.7
Schmidt, H.8
Angioni, C.9
Geisslinger, G.10
Grösch, S.11
-
16
-
-
41949140023
-
Characterization of ceramide synthase 2: Tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate
-
Laviad, E. L., L. Albee, I. Pankova-Kholmyansky, S. Epstein, H. Park, A. H. Merrill, Jr., and A. H. Futerman. 2008. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate. J. Biol. Chem. 283: 5677-5684.
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 5677-5684
-
-
Laviad, E.L.1
Albee, L.2
Pankova-Kholmyansky, I.3
Epstein, S.4
Park, H.5
Merrill Jr., A.H.6
Futerman, A.H.7
-
17
-
-
69449097633
-
The protein kinase IKKepsilon regulates energy balance in obese mice
-
Chiang, S. H., M. Bazuine, C. N. Lumeng, L. M. Geletka, J. Mowers, N. M. White, J. T. Ma, J. Zhou, N. Qi, D. Westcott, et al. 2009. The protein kinase IKKepsilon regulates energy balance in obese mice. Cell 138: 961-975.
-
(2009)
Cell
, vol.138
, pp. 961-975
-
-
Chiang, S.H.1
Bazuine, M.2
Lumeng, C.N.3
Geletka, L.M.4
Mowers, J.5
White, N.M.6
Ma, J.T.7
Zhou, J.8
Qi, N.9
Westcott, D.10
-
18
-
-
67649196932
-
Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis
-
Nath, N., M. Khan, M. K. Paintlia, I. Singh, M. N. Hoda, and S. Giri. 2009. Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. J. Immunol. 182: 8005-8014.
-
(2009)
J. Immunol.
, vol.182
, pp. 8005-8014
-
-
Nath, N.1
Khan, M.2
Paintlia, M.K.3
Singh, I.4
Hoda, M.N.5
Giri, S.6
-
19
-
-
63449116281
-
The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesis
-
Schiffmann, S., J. Sandner, R. Schmidt, K. Birod, I. Wobst, H. Schmidt, C. Angioni, G. Geisslinger, and S. Grösch. 2009. The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesis. J. Lipid Res. 50: 32-40.
-
(2009)
J. Lipid Res.
, vol.50
, pp. 32-40
-
-
Schiffmann, S.1
Sandner, J.2
Schmidt, R.3
Birod, K.4
Wobst, I.5
Schmidt, H.6
Angioni, C.7
Geisslinger, G.8
Grösch, S.9
-
20
-
-
65549143292
-
Ceramide synthases and ceramide levels are increased in breast cancer tissue
-
Schiffmann, S., J. Sandner, K. Birod, I. Wobst, C. Angioni, E. Ruckhäberle, M. Kaufmann, H. Ackermann, J. Lötsch, H. Schmidt, et al. 2009. Ceramide synthases and ceramide levels are increased in breast cancer tissue. Carcinogenesis 30: 745-752.
-
(2009)
Carcinogenesis
, vol.30
, pp. 745-752
-
-
Schiffmann, S.1
Sandner, J.2
Birod, K.3
Wobst, I.4
Angioni, C.5
Ruckhäberle, E.6
Kaufmann, M.7
Ackermann, H.8
Lötsch, J.9
Schmidt, H.10
-
21
-
-
0020448709
-
15N]nitrate in biological fluids
-
DOI 10.1016/0003-2697(82)90118-X
-
Green, L. C., D. A. Wagner, J. Glogowski, P. L. Skipper, J. S. Wishnok, and S. R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126: 131-138. (Pubitemid 13203451)
-
(1982)
Analytical Biochemistry
, vol.126
, Issue.1
, pp. 131-138
-
-
Green, L.C.1
Wagner, D.A.2
Glogowski, J.3
-
22
-
-
80052246111
-
Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool
-
Ajami, B., J. L. Bennett, C. Krieger, K. M. McNagny, and F. M. Rossi. 2011. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat. Neurosci. 14: 1142-1149.
-
(2011)
Nat. Neurosci.
, vol.14
, pp. 1142-1149
-
-
Ajami, B.1
Bennett, J.L.2
Krieger, C.3
McNagny, K.M.4
Rossi, F.M.5
-
23
-
-
78649752513
-
Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis
-
Domingues, H. S., M. Mues, H. Lassmann, H. Wekerle, and G. Krishnamoorthy. 2010. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. PLoS ONE 5: e15531.
-
(2010)
PLoS ONE
, vol.5
-
-
Domingues, H.S.1
Mues, M.2
Lassmann, H.3
Wekerle, H.4
Krishnamoorthy, G.5
-
24
-
-
0028061167
-
Nitric oxide as a potential pathological mechanism in demyelination: Its differential effects on primary glial cells in vitro
-
DOI 10.1016/0306-4522(94)90435-9
-
Mitrovic, B., L. J. Ignarro, S. Montestruque, A. Smoll, and J. E. Merrill. 1994. Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience 61: 575-585. (Pubitemid 24240305)
-
(1994)
Neuroscience
, vol.61
, Issue.3
, pp. 575-585
-
-
Mitrovic, B.1
-
25
-
-
0027161216
-
Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide
-
Merrill, J. E., L. J. Ignarro, M. P. Sherman, J. Melinek, and T. E. Lane. 1993. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151: 2132-2141. (Pubitemid 23235686)
-
(1993)
Journal of Immunology
, vol.151
, Issue.4
, pp. 2132-2141
-
-
Merrill, J.E.1
Ignarro, L.J.2
Sherman, M.P.3
Melinek, J.4
Lane, T.E.5
-
26
-
-
0029410743
-
Interferon-gamma-induced oligodendrocyte cell death: Implications for the pathogenesis of multiple sclerosis
-
Vartanian, T., Y. Li, M. Zhao, and K. Stefansson. 1995. Interferon-gamma-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol. Med. 1: 732-743. (Pubitemid 3013083)
-
(1995)
Molecular Medicine
, vol.1
, Issue.7
, pp. 732-743
-
-
Vartanian, T.1
Li, Y.2
Zhao, M.3
Stefansson, K.4
-
27
-
-
0035159618
-
Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of Valpha14 NK T cells
-
Pál, E., T. Tabira, T. Kawano, M. Taniguchi, S. Miyake, and T. Yamamura. 2001. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of Valpha 14 NK T cells. J. Immunol. 166: 662-668. (Pubitemid 32038491)
-
(2001)
Journal of Immunology
, vol.166
, Issue.1
, pp. 662-668
-
-
Pal, E.1
Tabira, T.2
Kawano, T.3
Taniguchi, M.4
Miyake, S.5
Yamamura, T.6
-
28
-
-
70350133784
-
Sphingolipids in inflammation: Pathological implications and potential therapeutic targets
-
Nixon, G. F. 2009. Sphingolipids in inflammation: pathological implications and potential therapeutic targets. Br. J. Pharmacol. 158: 982-993.
-
(2009)
Br. J. Pharmacol.
, vol.158
, pp. 982-993
-
-
Nixon, G.F.1
-
30
-
-
3042841602
-
A novel role of lactosylceramide in the regulation of lipopolysaccharide/ interferon-gamma-mediated inducible nitric oxide synthase gene expression: Implications for neuroinflammatory diseases
-
DOI 10.1523/JNEUROSCI.1271-04.2004
-
Pannu, R., J. S. Won, M. Khan, A. K. Singh, and I. Singh. 2004. A novel role of lactosylceramide in the regulation of lipopolysaccharide/interferon- gamma-mediated inducible nitric oxide synthase gene expression: implications for neuroinflammatory diseases. J. Neurosci. 24: 5942-5954. (Pubitemid 38859392)
-
(2004)
Journal of Neuroscience
, vol.24
, Issue.26
, pp. 5942-5954
-
-
Pannu, R.1
Won, J.-S.2
Khan, M.3
Singh, A.K.4
Singh, I.5
-
31
-
-
0035964774
-
Sphingomyelinase but not ceramide induces nitric oxide synthase expression in rat brain microglia
-
DOI 10.1016/S0304-3940(01)02162-0, PII S0304394001021620
-
Yang, M. S., I. Jou, H. Inn-Oc, and E. Joe. 2001. Sphingomyelinase but not ceramide induces nitric oxide synthase expression in rat brain microglia. Neurosci. Lett. 311: 133-136. (Pubitemid 32900623)
-
(2001)
Neuroscience Letters
, vol.311
, Issue.2
, pp. 133-136
-
-
Yang, M.-S.1
Jou, I.2
Inn-Oc, H.3
Joe, E.-H.4
-
32
-
-
28544446111
-
Monocyte and macrophage heterogeneity
-
DOI 10.1038/nri1733
-
Gordon, S., and P. R. Taylor. 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5: 953-964. (Pubitemid 41746764)
-
(2005)
Nature Reviews Immunology
, vol.5
, Issue.12
, pp. 953-964
-
-
Gordon, S.1
Taylor, P.R.2
-
33
-
-
77950534540
-
T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis
-
Axtell, R. C., B. A. de Jong, K. Boniface, L. F. van der Voort, R. Bhat, P. De Sarno, R. Naves, M. Han, F. Zhong, J. G. Castellanos, et al. 2010. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat. Med. 16: 406-412.
-
(2010)
Nat. Med.
, vol.16
, pp. 406-412
-
-
Axtell, R.C.1
De Jong, B.A.2
Boniface, K.3
Van Der Voort, L.F.4
Bhat, R.5
De Sarno, P.6
Naves, R.7
Han, M.8
Zhong, F.9
Castellanos, J.G.10
-
34
-
-
83555164961
-
Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury
-
Kim, S., A. J. Steelman, Y. Zhang, H. C. Kinney, and J. Li. 2012. Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury. Brain Pathol. 22: 41-57.
-
(2012)
Brain Pathol.
, vol.22
, pp. 41-57
-
-
Kim, S.1
Steelman, A.J.2
Zhang, Y.3
Kinney, H.C.4
Li, J.5
-
35
-
-
2942594278
-
Multiple sclerosis: Glatiramer acetate inhibits monocyte reactivity in vitro and in vivo
-
DOI 10.1093/brain/awh163
-
Weber, M. S., M. Starck, S. Wagenpfeil, E. Meinl, R. Hohlfeld, and C. Farina. 2004. Multiple sclerosis: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo. Brain 127: 1370-1378. (Pubitemid 38745515)
-
(2004)
Brain
, vol.127
, Issue.6
, pp. 1370-1378
-
-
Weber, M.S.1
Starck, M.2
Wagenpfeil, S.3
Meinl, E.4
Hohlfeld, R.5
Farina, C.6
-
36
-
-
0033015085
-
Interferon beta-1b treatment modulates TNFalpha and IFNgamma spontaneous gene expression in MS
-
Gayo, A., L. Mozo, A. Suárez, A. Tuñón, C. Lahoz, and C. Gutiérrez. 1999. Interferon beta-1b treatment modulates TNFalpha and IFNgamma spontaneous gene expression in MS. Neurology 52: 1764-1770. (Pubitemid 29260887)
-
(1999)
Neurology
, vol.52
, Issue.9
, pp. 1764-1770
-
-
Gayo, A.1
Mozo, L.2
Suarez, A.3
Tunon, A.4
Lahoz, C.5
Gutierrez, G.6
-
37
-
-
14844332032
-
CERT mediates intermembrane transfer of various molecular species of ceramides
-
DOI 10.1074/jbc.M409290200
-
Kumagai, K., S. Yasuda, K. Okemoto, M. Nishijima, S. Kobayashi, and K. Hanada. 2005. CERT mediates intermembrane transfer of various molecular species of ceramides. J. Biol. Chem. 280: 6488-6495. (Pubitemid 40341197)
-
(2005)
Journal of Biological Chemistry
, vol.280
, Issue.8
, pp. 6488-6495
-
-
Kumagai, K.1
Yasuda, S.2
Okemoto, K.3
Nishijima, M.4
Kobayashi, S.5
Hanada, K.6
-
38
-
-
33845338764
-
Sphingolipid metabolism in neural cells
-
DOI 10.1016/j.bbamem.2006.06.009, PII S0005273606002203, Sphingolipids, Apoptosis and Disease
-
van Echten-Deckert, G., and T. Herget. 2006. Sphingolipid metabolism in neural cells. Biochim. Biophys. Acta 1758: 1978-1994. (Pubitemid 44879360)
-
(2006)
Biochimica et Biophysica Acta - Biomembranes
, vol.1758
, Issue.12
, pp. 1978-1994
-
-
Van Echten-Deckert, G.1
Herget, T.2
-
39
-
-
84855918312
-
Ceramide synthases at the centre of sphingolipid metabolism and biology
-
Mullen, T. D., Y. A. Hannun, and L. M. Obeid. 2012. Ceramide synthases at the centre of sphingolipid metabolism and biology. Biochem. J. 441: 789-802.
-
(2012)
Biochem. J.
, vol.441
, pp. 789-802
-
-
Mullen, T.D.1
Hannun, Y.A.2
Obeid, L.M.3
-
40
-
-
0036694787
-
Identification of ceramide binding proteins in neuronal cells: A critical point of view
-
Elsen, L., R. Betz, G. Schwarzmann, K. Sandhoff, and G. van Echten-Deckert. 2002. Identification of ceramide binding proteins in neuronal cells: a critical point of view. Neurochem. Res. 27: 717-727.
-
(2002)
Neurochem. Res.
, vol.27
, pp. 717-727
-
-
Elsen, L.1
Betz, R.2
Schwarzmann, G.3
Sandhoff, K.4
Van Echten-Deckert, G.5
-
41
-
-
55749104704
-
A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis
-
Wheeler, D., V. V. Bandaru, P. A. Calabresi, A. Nath, and N. J. Haughey. 2008. A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis. Brain 131: 3092-3102.
-
(2008)
Brain
, vol.131
, pp. 3092-3102
-
-
Wheeler, D.1
Bandaru, V.V.2
Calabresi, P.A.3
Nath, A.4
Haughey, N.J.5
-
42
-
-
79953761792
-
A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis
-
Nikić, I., D. Merkler, C. Sorbara, M. Brinkoetter, M. Kreutzfeldt, F. M. Bareyre, W. Brück, D. Bishop, T. Misgeld, and M. Kerschensteiner. 2011. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat. Med. 17: 495-499.
-
(2011)
Nat. Med.
, vol.17
, pp. 495-499
-
-
Nikić, I.1
Merkler, D.2
Sorbara, C.3
Brinkoetter, M.4
Kreutzfeldt, M.5
Bareyre, F.M.6
Brück, W.7
Bishop, D.8
Misgeld, T.9
Kerschensteiner, M.10
-
43
-
-
0035554898
-
Multiple sclerosis: A two-stage disease
-
Steinman, L. 2001. Multiple sclerosis: a two-stage disease. Nat. Immunol. 2: 762-764.
-
(2001)
Nat. Immunol.
, vol.2
, pp. 762-764
-
-
Steinman, L.1
-
44
-
-
17844381010
-
Macrophages and neurodegeneration
-
DOI 10.1016/j.brainresrev.2004.12.008, Glial-Neuron Crosstalk in Neuroinflamation, Neurodegeneration and Neuroprotection
-
Hendriks, J. J., C. E. Teunissen, H. E. de Vries, and C. D. Dijkstra. 2005. Macrophages and neurodegeneration. Brain Res. Brain Res. Rev. 48: 185-195. (Pubitemid 40585749)
-
(2005)
Brain Research Reviews
, vol.48
, Issue.2
, pp. 185-195
-
-
Hendriks, J.J.A.1
Teunissen, C.E.2
De Vries, H.E.3
Dijkstra, C.D.4
|